COMMUNIQUÉS West-GlobeNewswire

Axsome Therapeutics to Participate in Upcoming Investor Conferences
03/11/2026
NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it [...]
Pasithea Therapeutics Announces FDA Clearance of IND for PAS-004 in Neurofibromatosis Type 1 (NF1)-Associated Cutaneous Neurofibromas (cNF)
03/11/2026
— FDA clearance allows Pasithea to advance PAS-004 for NF1-associated cNF, a condition affecting over 95% of people with NF1 and for which there are currently no FDA-approved systemic therapies . — MIAMI, Nov. 03, 2026 [...]
MitoRx Therapeutics Appoints Neil Anderson as Chief Business Officer
03/11/2026
Neil joins from Novo Nordisk and brings more than 20 years of experience in business development and strategic transactions Appointment strengthens MitoRx’s business development capabilities as the Company advances [...]
Rapport Therapeutics to Participate in Upcoming Investor Conferences
03/11/2026
BOSTON and SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small [...]
Jade Biosciences to Participate in Upcoming Conferences
03/11/2026
SAN FRANCISCO and VANCOUVER, British Columbia, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade” or the “Company”) (Nasdaq: JBIO), a clinical-stage biotechnology company focused on developing best-in- [...]
Tango Therapeutics to Participate in Guggenheim’s 3rd Annual Healthcare Innovation Conference
03/11/2026
BOSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX) today announced that Malte Peters, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a [...]
Evestia Clinical Acquires Emtex Life Science to Further Enhance its Global Full-Service Clinical Research Capabilities
03/11/2026
Acquisition significantly expands the depth and scale of Evestia Clinical’s established medical writing capabilities for biotech innovators and pharmaceutical companies The deal expands Evestia Clinical’s European [...]
Dr. Oetker Launches Fifth Year of Giuseppe Practice with a Pro, Welcomes P.K. Subban as the Program’s New Ambassador
03/11/2026
The Canadian hockey icon joins the next chapter of the community-based program, celebrating minor hockey teams that are making a difference in their communities TORONTO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Dr. Oetker [...]
Dr. Oetker lance la cinquième édition de Giuseppe Entraîne-toi avec un pro et accueille P.K. Subban comme nouvel ambassadeur
03/11/2026
L'ancien joueur vedette de la LNH et figure bien connue des Québécois rejoint cette nouvelle édition du programme, qui célèbre les équipes de hockey mineur ayant un impact positif dans leur communauté. TORONTO, 03 nov. [...]
BlossomHill Therapeutics to Present at Guggenheim’s 3rd Annual Healthcare Innovations Conference
03/11/2026
SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc. (Nasdaq: BLSM), a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to design and develop innovative [...]
Shopify Sustains Rapid Growth with Revenue Up 32% and Free Cash Flow Margin of 22%
03/11/2026
Internet, Everywhere, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Shopify announced today financial results for the quarter ended September 30, 2026. Shopify achieved 32% revenue growth (32% in constant currency) and a 22% free [...]
Human Appeal Receives Canadian Parliamentary Delegation to Rare Hospital in Northwest Syria
03/11/2026
MISSISSAUGA, Ontario, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Human Appeal Canada welcomed a Canadian Parliamentary and Humanitarian Delegation to Syria, which included a visit to Al-Iman Hospital in Sarmada , where a baby [...]
Upgrade of revenue and operating profit guidance
03/11/2026
ANNOUNCEMENT NO. 324 3 November 2026 ChemoMetec maintained its positive momentum in the months of the 2026/27 financial year, supported by higher-than-expected demand for our instruments, with the NC-203 being a key [...]
Transactions in connection with share buy-back program
03/11/2026
Company announcement no. 44 - 26 03 November 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company [...]
Global Pharmaceutical Company Commits to a Dual-Site Deal with AGC Biologics Exceeding €0.5 Billion
03/11/2026
Agreement builds on customer’s long-term deal in new Yokohama facility for five commercial biologics programs, now allocating an additional six commercial programs to Copenhagen facility to consolidate high-volume, [...]
GLORIA Study Team Receives the 2026 German University Medicine Prize for Its Glioblastoma Research with CXCL12 Inhibitor NOX-A12
03/11/2026
GLORIA Study Team Receives the 2026 German University Medicine Prize for Its Glioblastoma Research with CXCL12 Inhibitor NOX-A12 Researchers from six German university medical centers have received the 2026 German [...]
L'équipe de l'étude GLORIA reçoit le Prix allemand de la médecine universitaire 2026 pour ses travaux de recherche sur le glioblastome avec l'inhibiteur de CXCL12 NOX-A12
03/11/2026
L'équipe de l'étude GLORIA reçoit le Prix allemand de la médecine universitaire 2026 pour ses travaux de recherche sur le glioblastome avec l'inhibiteur de CXCL12 NOX-A12 Des chercheurs issus de six centres médicaux [...]
Coloplast A/S - Annual Report 2025/26 & Remuneration Report 2025/26
03/11/2026
FY 2025/26 organic growth was 6% and EBIT growth 1 in constant currencies was 4%. Reported revenue in DKK grew 4%, reflecting 2%-points negative impact from currencies. Organic growth rates by business area: Ostomy Care [...]
ONWARD Medical Delivers Revenue of EUR 2.5M in Q3 2026, with Sustained Commercial Momentum and Strong Clinical Execution
03/11/2026
EINDHOVEN, the Netherlands, Nov. 03, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and [...]

Pages